Trial intelligence / Profile preview

Influence of L-Arginine on Perfusion in Peripheral Bypass Surgery

2006-001852-11Phase 4Completed

Sponsor
Medical University of Vienna
Start
Oct 2006
Modality
Small Molecules, Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 4, single-arm trial of arginine in arteriosclerosis obliterans, sponsored by Medical University of Vienna. Primary endpoints: Local perfusion by laser Doppler flowmetry and Temperature gradient between elbow and fingertip. Started Oct 2006; status: completed.

02

Drugs

arginine
03

Conditions

arteriosclerosis obliterans

Beyond the preview

Go deeper on 2006-001852-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001852-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call